CTLA4 and neoplasm: Concordantly, in a murine tumour model, concomitant stimulation of ICOS and blockade of CTLA-4 has proven to elicit potent synergistic anti-tumour responses, pleading for clinical exploration of combination regimen of ICOS stimulation with ICI, especially anti-CTLA-4 antibodies (60, 61).